Quick Answer
Ernexa Therapeutics Inc. reported Gross Profit of $486.0 thousand for the year ending 2024.
- Ernexa Therapeutics Inc. showed an increase of +389.3% in Gross Profit from 2023 to 2024.
- This data is from Ernexa Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $0.00 | Q1 2023: -$50.0 thousand | Q3 2023: -$69.0 thousand | Q1 2024: -$14.0 thousand | Q2 2024: -$48.0 thousand | Q3 2024: $547.0 thousand.
- Historical annual values: Fiscal year 2024: $486.0 thousand | Fiscal year 2023: -$168.0 thousand | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: